Clinical Trials
6
Active:0
Completed:6
Trial Phases
3 Phases
Phase 1:4
Phase 2:1
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)• Click on a phase to view related trials
Phase 1
4 (66.7%)Phase 2
1 (16.7%)Phase 4
1 (16.7%)Bioequivalence Study Comparing Mucinex Extended-release 600 mg Tablets to Immediate-release Guaifenesin 600 mg in Healthy Volunteers
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- Drug: Vicks Cough Syrup for Chesty Coughs
- First Posted Date
- 2018-08-23
- Last Posted Date
- 2019-06-19
- Lead Sponsor
- Reckitt Benckiser Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03644095
Study to Characterize the Pharmacokinetics of 3 Marketed Products Containing 200 mg Guaifenesin in Healthy Volunteers.
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- Drug: Robitussin Extra Strength Chest CongestionDrug: Vicks Cough Syrup for Chesty CoughsDrug: Organ-I- NR tablet
- First Posted Date
- 2018-08-23
- Last Posted Date
- 2019-03-27
- Lead Sponsor
- Reckitt Benckiser Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03643575
Study to Evaluate the Pharmacokinetics of Mucinex 600 mg Extended-release Bi-layer Tablet in Healthy Volunteers
- First Posted Date
- 2018-08-23
- Last Posted Date
- 2019-02-28
- Lead Sponsor
- Reckitt Benckiser Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03644108
Mucinex® ER 600 mg Bi-layer Tablet Versus Guaifenesin Immediate Release (IR) 200 mg q4h
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2019-06-17
- Lead Sponsor
- Reckitt Benckiser Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03642262
Safety and Efficacy Study of Guaifenesin and Pseudoephedrine for Symptomatic Therapy to Treat Acute RTI
Phase 4
Completed
- Conditions
- Acute Upper Respiratory Track Infection
- Interventions
- Device: Placebo
- First Posted Date
- 2010-09-15
- Last Posted Date
- 2020-12-30
- Lead Sponsor
- Reckitt Benckiser Inc.
- Target Recruit Count
- 1179
- Registration Number
- NCT01202279
- Locations
- 🇺🇸
Clinical Research Advantage, Inc., Mesa, Arizona, United States
🇺🇸Med Center, Carmichael, California, United States
🇺🇸Research Center of Fresno, 3636 N. First Street, Suite 141, Fresno, California, United States
- Prev
- 1
- 2
- Next
News
No news found